Daily Blogs News

<img src="http://d.yimg.com/a/p/ap/20091117/capt.c23183bb363a420aa5f50c0658d9e20c.vaccine_revolution_nybz404.jpg?x=130&y=86&q=85&sig=qY923SG3d4n5K9MqEeX0lg–" align="left" height="86" width="130" alt="FILE – In this undated photo provided by Sanofi Pasteur, technicians perform production operations during a dry run at the company's influenza manufacturing facility in Swiftwater, Pa. Long seen as a sleepy, low-profit niche in the drug industry, this year investment in partnerships and other deals to develop and manufacture in vaccines is on a tear, seen as a crucial new path to growth. (AP Photo/Sanofi Pasteur, David W. Coulter) NO SALES” border=”0″ />AP – Malaria. Tuberculosis. Alzheimer’s disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler’s diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.

Vaccines on horizon for AIDS, Alzheimer’s, herpes
(AP)

Related posts:

1. Vaccines on horizon for AIDS, Alzheimer’s, herpes (AP)
2. Vaccines on Horizon for AIDS, Alzheimer’s
3. PHT Corporation’s Market Leading LogPad And StudyWorksTM EPRO Solutions Used In Sanofi Pasteur’s Phase II Study Of New Clostridium Difficile Vaccine